Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 142.5 INR -2.61% Market Closed
Market Cap: ₹306.9B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MEDANTA Price Targets Summary
Global Health Ltd

Wall Street analysts forecast MEDANTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 418.21 INR with a low forecast of 1 247.35 INR and a high forecast of 1 792.35 INR.

MEDANTA Lowest Forecast
Wall Street Target
1 247.35 INR
9% Upside
MEDANTA Average Forecast
Wall Street Target
1 418.21 INR
24% Upside
MEDANTA Highest Forecast
Wall Street Target
1 792.35 INR
57% Upside
Lowest
Price Target
1 247.35 INR
9% Upside
Average
Price Target
1 418.21 INR
24% Upside
Highest
Price Target
1 792.35 INR
57% Upside
Global Health Ltd Competitors:
Price Targets
FCL
FINEOS Corporation Holdings PLC
38% Upside
FCL
FINEOS Corporation Holdings PLC
38% Upside

Revenue
Forecast

26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 4 years the compound annual growth rate for Global Health Ltd's revenue is 26%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Operating Income
Forecast

76% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
76% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 4 years the compound annual growth rate for Global Health Ltd's operating income is 76%. The projected CAGR for the next 3 years is 19%.

What are analyst estimates?

Net Income
Forecast

102% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
102% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 4 years the compound annual growth rate for Global Health Ltd's net income is 102%. The projected CAGR for the next 3 years is 22%.

What are analyst estimates?

See Also

Summary
MEDANTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDANTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDANTA stock valuation using valuation multiples.
Wall Street Estimates
MEDANTA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDANTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDANTA's stock price target?
Price Target
1 418.21 INR

According to Wall Street analysts, the average 1-year price target for MEDANTA is 1 418.21 INR with a low forecast of 1 247.35 INR and a high forecast of 1 792.35 INR.

What is Global Health Ltd's Revenue forecast?
Projected CAGR
16%

For the last 4 years the compound annual growth rate for Global Health Ltd's revenue is 26%. The projected CAGR for the next 3 years is 16%.

What is Global Health Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Global Health Ltd's operating income is 76%. The projected CAGR for the next 3 years is 19%.

What is Global Health Ltd's Net Income forecast?
Projected CAGR
22%

For the last 4 years the compound annual growth rate for Global Health Ltd's net income is 102%. The projected CAGR for the next 3 years is 22%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.